5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid

We are 5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid CAS:143382-03-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 143382-03-0
Product Name: 5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid
Other Name:
5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid
5-(Methoxymethyl)-2,3-pyridinedicarboxylic acid
 
Density: 1.4±0.1 g/cm3
Boiling Point: 428.6±45.0 °C at 760 mmHg
Molecular Formula: C9H9NO5
Molecular Weight: 211.171
Flash Point: 213.0±28.7 °C
Exact Mass: 211.048065
PSA: 96.72000
LogP: -1.70
Vapour Pressure: 0.0±1.1 mmHg at 25°C
Index of Refraction: 1.589
 
Specification
Appearance: Solid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Imazamox CAS: 114311-32-9.
Be used as pesticide intermediate, mainly used to synthesize herbicide imazamox.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid


Related News: U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.Ácido 4-etilfenilborónico CAS:63139-21-9 U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.2-chloro-4-methyl-3-nitropyridine CAS:23056-39-5 Retrogenix holds two Queen’s Awards for Enterprise, the UK’s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA.2-(2-Chloroethoxy)ethanol Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.

Related Products
Product Name
Laurocapram View Details
2-(2-benzylphenyl)propan-2-ol View Details
D-Proline tert-Butyl Ester Hydrochloride View Details
Bis(dicyclohexylphosphino)methane manufacturer Benzenesulfonyl Chloride manufacturer 5-[(2-Hydroxyethyl)Amino]-o-Cresol manufacturer Ethyl (2R,4R)-4-methyl-2-piperidinecarboxylate manufacturer N-Ac-D,L-Phg-OH manufacturer